# Posterior Tibial Nerve Stimulation (PTNS) Plus Mirabegron to Treat Refractory OAB Symptoms (PTNS-M Study)

> **NCT04907032** · PHASE4 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 54 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** Mirabegron 50 MG
- **DEVICE:** Posterior Tibial Nerve Stimulation (PTNS)

## Key facts

- **NCT ID:** NCT04907032
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-01
- **Primary completion:** 2023-04-01
- **Final completion:** 2023-04-15
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2023-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04907032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04907032, "Posterior Tibial Nerve Stimulation (PTNS) Plus Mirabegron to Treat Refractory OAB Symptoms (PTNS-M Study)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04907032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*